NEW YORK – Swedish life sciences firm Olink Proteomics has launched a version of its proximity extension assay (PEA) proteomics technology that uses next-generation sequencing for readout of results.
The NGS approach will allow the company to lower assay costs while increasing its throughput and multiplexing capabilities, said Olink CEO Jon Heimer.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.